Interleukin-33/ST2 system attenuates aldosterone-induced adipogenesis and inflammation

Molecular and Cellular Endocrinology

Volumn 411, Issue , 2015, Pages 20-27

  Martínez Martínez, Ernesto ^a   Cachofeiro, Victoria ^b   Rousseau, Elodie ^c   Álvarez, Virginia ^a,d   Calvier, Laurent ^c   Fernández Celis, Amaya ^a   Leroy, Céline ^c   Miana, María ^b   Jurado López, Raquel ^b   Briones, Ana M ^e   Jaisser, Frederic ^c,f   Zannad, Faiez ^c   Rossignol, Patrick ^c   López Andrés, Natalia ^a,c  

^a Red de Investigación en Servicios de Salud en Enfermedades Crónicas   (Spain)

^b UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^c UNIVERSITÉ DE LORRAINE   (France)

^d Universidad Pública de Navarra   (Spain)

^e UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^f CENTRE DE RECHERCHE DES CORDELIERS   (France)

Author keywords

Adipocyte differentiation; Adipose tissue; Aldosterone; IL 33 ST2 system

Indexed keywords

ALDOSTERONE; INTERLEUKIN 33; PROTEIN ST2; REGULATOR PROTEIN; UNCLASSIFIED DRUG; IL1RL1 PROTEIN, MOUSE; INTERLEUKIN RECEPTOR;

ADIPOCYTE; ADIPOGENESIS; ADIPOSE TISSUE; ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; INFLAMMATION; LIPID STORAGE; MALE; NONHUMAN; OBESITY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; RAT; SIGNAL TRANSDUCTION; 3T3 CELL LINE; ANIMAL; C57BL MOUSE; DRUG EFFECTS; LIPID DIET; METABOLISM; MOUSE; PHYSIOLOGY; WISTAR RAT;

3T3-L1 CELLS; ADIPOGENESIS; ADIPOSE TISSUE; ALDOSTERONE; ANIMALS; DIET, HIGH-FAT; INFLAMMATION; INTERLEUKIN-33; MALE; MICE; MICE, INBRED C57BL; OBESITY; RATS; RATS, WISTAR; RECEPTORS, INTERLEUKIN;

EID: 84930181376     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2015.04.007     Document Type: Article

References (31)

1. Ahlqvist E., Osmark P., Kuulasmaa T., Pilgaard K., Omar B., et al. Link between GIP and osteopontin in adipose tissue and insulin resistance. Diabetes 2013, 62:2088-2094.
2. Bartunek J., Delrue L., Van D.F., Muller O., Casselman F., et al. Nonmyocardial production of ST2 protein in human hypertrophy and failure is related to diastolic load. J. Am. Coll. Cardiol 2008, 52:2166-2174.
3. Briones A.M., Nguyen Dinh C.A., Callera G.E., Yogi A., Burger D., et al. Adipocytes produce aldosterone through calcineurin-dependent signaling pathways: implications in diabetes mellitus-associated obesity and vascular dysfunction. Hypertension 2012, 59:1069-1078.
4. Calvier L., Miana M., Reboul P., Cachofeiro V., Martinez-Martinez E., et al. Galectin-3 mediates aldosterone-induced vascular fibrosis. Arterioscler. Thromb. Vasc. Biol 2013, 33:67-75.
5. Campion J., Lahera V., Cachofeiro V., Maestro B., Davila N., et al. In vivo tissue specific modulation of rat insulin receptor gene expression in an experimental model of mineralocorticoid excess. Mol. Cell. Biochem 1998, 185:177-182.
6. Caprio M., Feve B., Claes A., Viengchareun S., Lombes M., et al. Pivotal role of the mineralocorticoid receptor in corticosteroid-induced adipogenesis. FASEB J. 2007, 21:2185-2194.
7. Caprio M., Antelmi A., Chetrite G., Muscat A., Mammi C., et al. Antiadipogenic effects of the mineralocorticoid receptor antagonist drospirenone: potential implications for the treatment of metabolic syndrome. Endocrinology 2011, 152:113-125.
8. Daniele G., Guardado M.R., Winnier D., Fiorentino T.V., Pengou Z., et al. The inflammatory status score including IL-6, TNF-alpha, osteopontin, fractalkine, MCP-1 and adiponectin underlies whole-body insulin resistance and hyperglycemia in type 2 diabetes mellitus. Acta Diabetol 2014, 51:123-131.
9. Demyanets S., Kaun C., Pentz R., Krychtiuk K.A., Rauscher S., et al. Components of the interleukin-33/ST2 system are differentially expressed and regulated in human cardiac cells and in cells of the cardiac vasculature. J. Mol. Cell. Cardiol 2013, 60:16-26.
10. Engeli S., Schling P., Gorzelniak K., Boschmann M., Janke J., et al. The adipose-tissue renin-angiotensin-aldosterone system: role in the metabolic syndrome?. Int. J. Biochem. Cell Biol 2003, 35:807-825.
11. Fousteris E., Melidonis A., Panoutsopoulos G., Tzirogiannis K., Foussas S., et al. Toll/interleukin-1 receptor member ST2 exhibits higher soluble levels in type 2 diabetes, especially when accompanied with left ventricular diastolic dysfunction. Cardiovasc. Diabetol 2011, 10:101.
12. Guo C., Ricchiuti V., Lian B.Q., Yao T.M., Coutinho P., et al. Mineralocorticoid receptor blockade reverses obesity-related changes in expression of adiponectin, peroxisome proliferator-activated receptor-gamma, and proinflammatory adipokines. Circulation 2008, 117:2253-2261.
13. Hoppmann J., Perwitz N., Meier B., Fasshauer M., Hadaschik D., et al. The balance between gluco- and mineralo-corticoid action critically determines inflammatory adipocyte responses. J. Endocrinol 2010, 204:153-164.
14. Krug A.W., Ehrhart-Bornstein M. Aldosterone and metabolic syndrome: is increased aldosterone in metabolic syndrome patients an additional risk factor?. Hypertension 2008, 51:1252-1258.
15. Li H., Tago K., Io K., Kuroiwa K., Arai T., et al. The cloning and nucleotide sequence of human ST2L cDNA. Genomics 2000, 67:284-290.
16. Maeso R., Rodrigo E., Munoz-Garcia R., Navarro-Cid J., Ruilope L.M., et al. Chronic treatment with losartan ameliorates vascular dysfunction induced by aging in spontaneously hypertensive rats. J. Hypertens 1998, 16:665-672.
17. Makki K., Froguel P., Wolowczuk I. Adipose tissue in obesity-related inflammation and insulin resistance: cells, cytokines, and chemokines. ISRN Inflamm 2013, 2013:139239.
18. Martínez-Martínez E., Jurado-López R., Valero-Muñoz M., Bartolomé M.V., Ballesteros S., et al. Leptin induces cardiac fibrosis through galectin-3, mTOR and oxidative stress: potential role in obesity. J. Hypertens 2014, 32(5):1104-1114.
19. Martinez-Martinez E., Miana M., Jurado-Lopez R., Rousseau E., Rossignol P., et al. A role for soluble ST2 in vascular remodeling associated with obesity in rats. PLoS ONE 2013, 8:e79176.
20. Miller A.M., Asquith D.L., Hueber A.J., Anderson L.A., Holmes W.M., et al. Interleukin-33 induces protective effects in adipose tissue inflammation during obesity in mice. Circ. Res 2010, 107:650-658.
21. Miller A.M., Purves D., McConnachie A., Asquith D.L., Batty G.D., et al. Soluble ST2 associates with diabetes but not established cardiovascular risk factors: a new inflammatory pathway of relevance to diabetes?. PLoS ONE 2012, 7:e47830.
22. Palmer G., Lipsky B.P., Smithgall M.D., Meininger D., Siu S., et al. The IL-1 receptor accessory protein (AcP) is required for IL-33 signaling and soluble AcP enhances the ability of soluble ST2 to inhibit IL-33. Cytokine 2008, 42:358-364.
23. Ribstein J., Du C.G., Fesler P., Mimran A. Relative glomerular hyperfiltration in primary aldosteronism. J. Am. Soc. Nephrol 2005, 16:1320-1325.
24. Rondinone C.M., Rodbard D., Baker M.E. Aldosterone stimulated differentiation of mouse 3T3-L1 cells into adipocytes. Endocrinology 1993, 132:2421-2426.
25. Rossi G.P., Belfiore A., Bernini G., Fabris B., Caridi G., et al. Body mass index predicts plasma aldosterone concentrations in overweight-obese primary hypertensive patients. J. Clin. Endocrinol. Metab 2008, 93:2566-2571.
26. Schafer N., Lohmann C., Winnik S., van Tits L.J., Miranda M.X., et al. Endothelial mineralocorticoid receptor activation mediates endothelial dysfunction in diet-induced obesity. Eur. Heart J. 2013, 34:3515-3524.
27. Schmieder R.E., Hilgers K.F., Schlaich M.P., Schmidt B.M. Renin-angiotensin system and cardiovascular risk. Lancet 2007, 369:1208-1219.
28. Schmitz J., Owyang A., Oldham E., Song Y., Murphy E., et al. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 2005, 23:479-490.
29. Tago K., Noda T., Hayakawa M., Iwahana H., Yanagisawa K., et al. Tissue distribution and subcellular localization of a variant form of the human ST2 gene product, ST2V. Biochem. Biophys. Res. Commun 2001, 285:1377-1383.
30. Underwood P.C., Adler G.K. The renin angiotensin aldosterone system and insulin resistance in humans. Curr. Hypertens. Rep 2013, 15:59-70.
31. Zeyda M., Wernly B., Demyanets S., Kaun C., Hammerle M., et al. Severe obesity increases adipose tissue expression of interleukin-33 and its receptor ST2, both predominantly detectable in endothelial cells of human adipose tissue. Int. J. Obes. (Lond) 2013, 37:658-665.